Showing 1 - 7 of 7 Items
Showing 1 - 7 of 7 Items
Sort By: Relevance
Conference Material
|Video
Mental health in the Mbya Guarani population: Analysis of cultural practices in search of well being
2024-11-05 • MSF Scientific Days Latin America 2024
2024-11-05 • MSF Scientific Days Latin America 2024
Conference Material
|Abstract
2024-11-05 • MSF Scientific Days Latin America 2024
2024-11-05 • MSF Scientific Days Latin America 2024
Given the relevant prevalence of mental health problems in Mbyá Guaraní indigenous population and the lack of specific information for a more effective care in these communities, it ...
Journal Article
|Research
2012-08-28 • PLOS Medicine
2012-08-28 • PLOS Medicine
Treatment of multidrug resistant tuberculosis (MDR-TB) is lengthy, toxic, expensive, and has generally poor outcomes. We undertook an individual patient data meta-analysis to assess the ...
Journal Article
|Research
2010-06-01 • AIDS Care
2010-06-01 • AIDS Care
Expanded access to antiretroviral therapy (ART) offers opportunities to strengthen HIV prevention in resource-limited settings. We invited 27 ART programmes from urban settings in Africa...
Journal Article
|Research
2021-05-01 • Travel Medicine and Infectious Disease
2021-05-01 • Travel Medicine and Infectious Disease
BACKGROUND
Determinants of vaccine acceptance are multifactorial, complex, and in most cases, context-dependent. We determined the prevalence of COVID-19 vaccination intention (VI) a...
Determinants of vaccine acceptance are multifactorial, complex, and in most cases, context-dependent. We determined the prevalence of COVID-19 vaccination intention (VI) a...
Journal Article
|Research
2012-12-04 • International Journal of Tuberculosis and Lung Disease
2012-12-04 • International Journal of Tuberculosis and Lung Disease
BACKGROUND: Scaling up treatment for multidrug-resistant tuberculosis is a global health priority. However, current treatment regimens are long and associated with side effects, and defa...
Journal Article
|Research
2013-02-05 • PLOS One
2013-02-05 • PLOS One
Co-infection with Hepatitis C (HCV) and HIV is common and HIV accelerates hepatic disease progression due to HCV. However, access to HCV treatment is limited and success rates are genera...